Hua, Peng http://orcid.org/0000-0003-3774-5033
Badat, Mohsin http://orcid.org/0000-0003-0744-5427
Hanssen, Lars L. P. http://orcid.org/0000-0002-2551-2278
Hentges, Lance D. http://orcid.org/0000-0001-6327-6774
Crump, Nicholas http://orcid.org/0000-0001-9610-6763
Downes, Damien J. http://orcid.org/0000-0002-5034-0869
Jeziorska, Danuta M.
Oudelaar, A. Marieke http://orcid.org/0000-0002-4016-6158
Schwessinger, Ron http://orcid.org/0000-0001-7829-8503
Taylor, Stephen http://orcid.org/0000-0002-3559-4334
Milne, Thomas A. http://orcid.org/0000-0002-0413-4271
Hughes, Jim R. http://orcid.org/0000-0002-8955-7256
Higgs, Doug R. http://orcid.org/0000-0003-3579-8705
Davies, James O. J. http://orcid.org/0000-0002-4108-4357
Article History
Received: 25 February 2020
Accepted: 13 May 2021
First Online: 9 June 2021
Competing interests
: J.O.J.D., D.M.J. and J.R.H. are co-founders of Nucleome Therapeutics. J.O.J.D., J.R.H., D.J.D. and R.S. provide consultancy to the company and D.M.J. is an employee. J.O.J.D. and J.R.H. have filed a provisional patent application on this work (PCT/GB2020/050253).